Source:http://linkedlifedata.com/resource/pubmed/id/13604315
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-4
|
pubmed:dateCreated |
1959-12-1
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/CORTISONE/therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/ISONIAZID/therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/MULTIPLE SCLEROSIS/therapy,
http://linkedlifedata.com/resource/pubmed/keyword/STREPTOMYCIN/therapeutic use
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0043-5384
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
326-56
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1958
|
pubmed:articleTitle |
[Trials of therapy of multiple sclerosis based on pathogenetic aspects].
|
pubmed:publicationType |
Journal Article
|